Insights into the molecular basis of ligand binding by the cholecystokinin receptor

被引:1
作者
Miller, LJ [1 ]
Ding, XQ [1 ]
机构
[1] Mayo Clin & Mayo Fdn, Ctr Basic Res Digest Dis, Rochester, MN 55905 USA
关键词
cholecystokinin; G-protein-coupled receptors; photoaffinity labeling; mutagenesis;
D O I
10.1159/000055832
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The receptor for the peptide hormone, cholecystokinin, is a G-protein-coupled receptor in the rhodopsin/beta -adrenergic receptor family. A number of methodological approaches have been utilized to gain insights into the molecular basis for natural peptide ligand binding and activation of this physiologically important receptor. Insights into this have come from sequence analysis, ligand and receptor structure-activity data, receptor mutagenesis, conformational analysis of ligand and receptor fragments, and photoaffinity labeling. In this work, we review the contributions of each of these complementary approaches and provide a current integrated view of the active complex of cholecystokinin bound to its receptor. Copyright (C) 2001 S. Karger AG, Basel and IAP.
引用
收藏
页码:336 / 342
页数:7
相关论文
共 50 条
[21]   Involvement of cholecystokinin within craving for cocaine: role of cholecystokinin receptor ligands [J].
Crespi, F ;
Corsi, M ;
Reggiani, A ;
Ratti, E ;
Gaviraghi, G .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2000, 9 (10) :2249-2258
[22]   Cholecystokinin and cholecystokinin-A receptor: An attractive treatment strategy for biliary dyskinesia? [J].
Chang, Jun ;
Liu, Yan ;
Jiang, Ting-Can ;
Zhao, Lan ;
Liu, Jian-Wei .
WORLD JOURNAL OF GASTROENTEROLOGY, 2024, 30 (03) :283-285
[23]   Molecular characterization of a ligand-tethered parathyroid hormone receptor [J].
Monticelli, L ;
Mammi, S ;
Mierke, DF .
BIOPHYSICAL CHEMISTRY, 2002, 95 (02) :165-172
[24]   Molecular basis of receptor/G-protein-coupling selectivity [J].
Wess, J .
PHARMACOLOGY & THERAPEUTICS, 1998, 80 (03) :231-264
[25]   The ligand binding site of NPY at the rat Y1 receptor investigated by site-directed mutagenesis and molecular modeling [J].
Robin-Jagerschmidt, C ;
Sylte, I ;
Bihoreau, C ;
Hendricksen, L ;
Calvet, A ;
Dahl, SG ;
Bénicourt, C .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1998, 139 (1-2) :187-198
[26]   Advances in cannabinoid receptors pharmacology: from receptor structural insights to ligand discovery [J].
Shen, Si-yuan ;
Wu, Chao ;
Yang, Zhi-qian ;
Wang, Ke-xin ;
Shao, Zhen-hua ;
Yan, Wei .
ACTA PHARMACOLOGICA SINICA, 2025, :1495-1510
[27]   Molecular mechanisms of ligand binding, signaling, and regulation within the superfamily of G-protein-coupled receptors: molecular modeling and mutagenesis approaches to receptor structure and function [J].
Kristiansen, K .
PHARMACOLOGY & THERAPEUTICS, 2004, 103 (01) :21-80
[28]   Synthetic studies on cholecystokinin receptor antagonists [J].
Satoh, Y .
JOURNAL OF SYNTHETIC ORGANIC CHEMISTRY JAPAN, 2000, 58 (08) :766-775
[29]   Discovery of novel antagonists of human neurotensin receptor 1 on the basis of ligand and protein structure [J].
Zhang, Guo ;
Wang, Kun ;
Li, Xiao-Dan ;
Zhang, Dong-Ling ;
Xu, Feng .
BIOMEDICINE & PHARMACOTHERAPY, 2016, 84 :147-157
[30]   Molecular and functional insights into gonadotropin hormone receptor dimerization and oligomerization [J].
Agwuegbo, Uche C. ;
Jonas, Kim C. .
MINERVA GINECOLOGICA, 2018, 70 (05) :539-548